Search results for “Antibody-dependent cell cytotoxicity” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 112 patents, we discovered top 46 key players by total patent application. Cogent Biosciences, Inc., Janssen Biotech, Sanofi SA are dominant in this area. They take 23.21% of the total patent filing.
Cogent Biosciences, Inc.
Massachusetts, United States
Patent: 10
Janssen Biotech
Belgium
Patent: 9
Sanofi SA
France
Patent: 7
Asahi Kasei Medical Co., Ltd.
Tokyo-to, Japan
Patent: 6
Svar Life Science AB
Sweden
Patent: 6
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 6
Sinomab Bioscience Ltd.
Hong Kong SAR, China
Patent: 4
Roche Glycart AG
ZURICH, Switzerland
Patent: 4
Sanofi-Aventis SA
Spain
Patent: 4
Kindred Biosciences, Inc.
California, United States
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 4 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 2
STARTUP
IO Biotech ApS
Hovedstaden, Denmark
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 49 patents applied in the last 5 years. We discover 26 most active companies in this area. The fast-growing Cogent Biosciences, Inc., Regents of the University of California, Svar Life Science AB take 36.73% of patent filing during this period.
Cogent Biosciences, Inc.
Massachusetts, United States
Patent: 10
Regents of the University of California
California, United States
Patent: 4
Svar Life Science AB
Sweden
Patent: 4
University of Copenhagen
Hovedstaden, Denmark
Patent: 3
Technical University of Denmark
Hovedstaden, Denmark
Patent: 3
United States of America
United States
Patent: 3
Humanitas University
Italy
Patent: 3
Kindred Biosciences, Inc.
California, United States
Patent: 3
Humanitas Mirasole SpA
MILAN, Italy
Patent: 3
Zhejiang Bola Atu Pharmaceutical Technology Co., Ltd.
China
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 49 patents in last 5 years, we discover 21 new entrants. Cogent Biosciences, Inc., Regents of the University of California, United States of America are the most active new entrants in this area.
Cogent Biosciences, Inc.
Massachusetts, United States
Patent: 10
Regents of the University of California
California, United States
Patent: 4
United States of America
United States
Patent: 3
Humanitas University
Italy
Patent: 3
Kindred Biosciences, Inc.
California, United States
Patent: 3
Humanitas Mirasole SpA
MILAN, Italy
Patent: 3
Zhejiang Bola Atu Pharmaceutical Technology Co., Ltd.
China
Patent: 3
STARTUP
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 2
STARTUP
IO Biotech ApS
Hovedstaden, Denmark
Patent: 2
Istituto Europeo di Oncologia SRL
Lombardia, Italy
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 28 patents, we discovered top 6 universities and scientific research institutions by total patent application. National University of Singapore, Technical University of Denmark, University of Copenhagen are dominant in this area. They take 60.71% of the total patent filing.
National University of Singapore
Central Region, Singapore
Patent: 6
Technical University of Denmark
Hovedstaden, Denmark
Patent: 4
University of Copenhagen
Hovedstaden, Denmark
Patent: 4
Humanitas University
Italy
Patent: 3
Emory University
Georgia, United States
Patent: 1
Osaka University
Osaka-fu, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: